Buhlmann公司是一家瑞士公司，专注于胃肠病学、量子蓝、自身免疫性、细胞过敏、神经免疫学、临床化学、时间生物学、其他免疫分析相关产品的研发、生产、销售。

BÜHLMANN is a fully independent, medium sized and family owned Swiss company. The company was founded in 1976 and has continuously developed over the years. Sister companies have been established in Austria (BÜHLMANN in Austria GmbH) in 1996, in France (BÜHLMANN France SAS) in 2002, in Italy (BUHLMANN Italia srl) in 2009 and Brasil (BÜHLMANN Brasil) in 2013. Since 2005, BÜHLMANN products are directly distributed in Germany.

Buhlmann公司的主要产品包括：

Gastroenterology

Quantum Blue

Autoimmunity

Cellular Allergy

Neuroimmunology

Clinical Chemistry

Chronobiology

Special Products

Other Immunoassays

Proteintech Group，Inc.于2001年在美国芝加哥成立，是一家专门从事研发、生产和销售抗体及重组蛋白的生物公司。针对生物前沿的热点研究，为科研工作者提供新颖独特的一抗及相关产品。公司自创建以来，一贯以感受现代生物学发展的脉搏，把握当今生物学先进的技术，为生物学研究提供所需的抗体、蛋白及相关产品，为生物学界同仁提供优良服务为己任。公司拥有国际一流管理体系，确立了一整套生物科技企业的良性运营模式，建立起了坚实而广泛的欧美以及国内市场销售体系，产品和服务已为国内外一流实验室所接纳和采用，在当今方兴未艾的人类蛋白质组计划已占据了一席之地。

PROTEINTECH的主要产品包括：

ELISA Kits

Fusion Proteins

Monoclonal Antibodies

Polyclonal Antibodies

Secondary Antibodies

Tag/Control Antibodies

Custom production

按照研究领域细分：

Cancer

Cardiovascular

Cell Division and Proliferation

Developmental biology

Epigenetics

Immunology

Metabolism

Neuroscience

Signal Transduction

Stem cells

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

Dendritics公司主要关注人类树突状细胞，希望找到能够促使CD34+造血前体细胞转化为树突状细胞（在GM-CSF和TNF-alpha存在的情况下）的细胞因子。在1992-2005年间，大量的研究使得研究者对人类树突状细胞的产生、细胞通路、C-type凝集素受体的功能及Toll-like受体的活性有了更深的理解。

DENDRITICS was started in 2005 by former members of SCHERING PLOUGH Laboratory for Immunological Research (LIR) in Dardilly, France. From their long experience at LIR, the team members of DENDRITICS have gathered complementary scientific and technological knowledge in different areas of immunology. The initial focus of LIR was in the biology of B lymphocytes, elaboration of human monoclonal antibodies, and in cytokine discovery (IL-3, IL-4, IL-7, IL-10, IL-17, GM-CSF) together with our colleagues of DNAX Research Institute in Palo Alto, California.

Our interest in cytokines led to the finding that human dendritic cells (DCs) could be generated in vitro from CD34+ hematopoietic progenitors cultured in the presence of GM-CSF and TNF-alpha.

The period from 1992 to 2005 saw the specialization of LIR in DC biology and was fuelled by a large-scale effort to discover and study the function of genes specifically expressed by these cells. This program led to a number of findings that contributed in particular to understanding the heterogeneity of DCs, the pathways regulating DC migration, the function of C-type lectin receptors in DCs and the activity of Toll-like receptors in DCs. Many novel genes were discovered through screening of cDNA libraries or through monoclonal antibodies raised against DCs.

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com